[Federal Register: May 26, 1999 (Volume 64, Number 101)]
[Notices]               
[Page 28499-28500]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26my99-90]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

NAME: Advisory Committee on Immunization Practices (ACIP).

TIMES AND DATES:
8:45 a.m.-5:30 p.m., June 16, 1999.
8 a.m.-3 p.m., June 17, 1999.

PLACE: Atlanta Marriott North Central, 2000 Century Boulevard, NE, 
Atlanta, Georgia 30345-3377.

STATUS: Open to the public, limited only by the space available.

Purpose

    The Committee is charged with advising the Director, CDC, on the 
appropriate uses of immunizing agents. In addition, under 42 U.S.C. 
Sec. 1396s, the Committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines.

Matters To Be Discussed

    The agenda will include updates from the Food and Drug 
Administration; update from the National Center for Infectious 
Diseases; the National Immunization Program; the Vaccine Injury 
Compensation Program; the National Vaccine Program; the adult 
immunization working group; the general recommendations working group; 
issues related to transition to an

[[Page 28500]]

all-IPV schedule; revision of hepatitis B recommendations; consolidated 
Vaccines for Children resolution for hepatitis B vaccine; 
recommendation for use of pneumococcal conjugate vaccine; revaccination 
with pneumococcal polysaccharide vaccine; pneumococcal polysaccharide 
vaccine in adults with HIV infection; update on influenza; American 
Academy of Family Physicians recommendation for universal influenza 
vaccination starting at age 50 years; status of immunization of bone 
marrow transplant (BMT) recipients publication; discussion on vaccines 
related to bioterrorism; teaching immunization for medical education 
(TIME) project; recommendations for nursing home immunization: a HCFA/
CDC collaboration; cost-effectiveness and economic analysis of 
immunization compared to other health interventions; electronic 
updating of ACIP recommendations; and Institute of Medicine report on 
priorities for vaccines development. Other matters of relevance among 
the committee's objectives may be discussed.
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR MORE INFORMATION: John R. Livengood, M.D., Director, 
Division of Epidemiology and Surveillance, National Immunization 
Program, CDC, 1600 Clifton Road, NE, M/S E-61, Atlanta, Georgia 30333, 
telephone 404/639-8254.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

    Dated: May 20, 1999.
Carolyn J. Russell
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 99-13333 Filed 5-25-99; 8:45 am]
BILLING CODE 4163-18-P